Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Enterprise Value (2024 - 2025)

Evommune (EVMN) has disclosed Enterprise Value for 2 consecutive years, with -$149.2 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 107.11% to -$149.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$149.2 million through Dec 2025, down 107.11% year-over-year, with the annual reading at -$149.2 million for FY2025, 107.11% down from the prior year.
  • Enterprise Value for Q4 2025 was -$149.2 million at Evommune, down from -$76.1 million in the prior quarter.
  • The five-year high for Enterprise Value was -$18.1 million in Q3 2024, with the low at -$149.2 million in Q4 2025.